Citius Pharmaceuticals, Inc. (CTXR) stock
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.51+0.01 (+2.27%)
Close on Nov 20, 2026Market cap $13.96MP/E –Yield –
Citius Pharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2018 it was $0.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Sep 30, 2018 | $0 | – |
| FY2017 | Sep 30, 2017 | $0 | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $1.00M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $1.34M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $3.15M | – |
See a number that looks wrong?